Company Filing History:
Years Active: 2019
Title: Innovations in Tumor Prognosis by Srivalleesha Mallidi
Introduction
Srivalleesha Mallidi is an accomplished inventor based in Boston, MA (US). He has made significant contributions to the field of medical technology, particularly in the area of tumor prognosis. His innovative approach focuses on measuring blood oxygen saturation to predict tumor recurrence.
Latest Patents
Mallidi holds a patent for a method titled "Prediction of tumor recurrence by measuring oxygen saturation." This patent describes a technique for measuring differential blood oxygen saturation in a solid tumor. The method involves obtaining a first oxygenation image of the tumor before, during, or immediately after the administration of vascular therapy. Following this, a second oxygenation image is captured after a devascularization time period. By comparing these two images, a differential blood oxygen saturation value is determined. This value can then be compared to a blood oxygen saturation necrosis value to provide a prognosis for tumor recurrence or to guide treatment decisions.
Career Highlights
Mallidi is affiliated with The General Hospital Corporation, where he applies his expertise in medical imaging and tumor analysis. His work has the potential to significantly impact patient outcomes by providing more accurate prognoses for tumor recurrence.
Collaborations
One of his notable collaborators is Tayyaba Hasan, with whom he has worked on various projects related to medical imaging and tumor research.
Conclusion
Srivalleesha Mallidi's innovative methods in measuring blood oxygen saturation represent a significant advancement in the field of oncology. His contributions are paving the way for improved prognostic techniques in tumor management.